SIE, Series 7, 63, 86 and 87 registration with FINRA upon or within 60 days of hire. Series 24 registration with FINRA upon or within 90 days of hire. Knowledge of biopharma industry i.e., science medicine, RDmanufacturing commercial processes, interplay among various stakeholders in the industry, awareness of trends and recent developments and ability to research learn synthesize findings rapidly on new topics. Ownership of largescale project execution grounded on fundamentals of problem solving, including defining problem statement or question, breaking it down into its components and use the structure to guide and organize activities of experts from a crossfunctional team. Gathering and synthesizing large volumes of financial, business intelligence, and clinicalmedical journal data from a number of secondary database tools. Leading and delivering on several crossfunctional, strategic projects e.g., evaluation of an MA opportunity, new business proposals, spanning across drug discovery, clinical development, manufacturing, and commercial functions. Strong quantitative and qualitative analytic skills, including financial analysis, in order to develop market and valuation models to capture opportunities and risks for commercial and pipeline products within the portfolio of covered biopharmaceutical companies. Comfort in leading and keeping teams motivated team through translation of complex tasks into time and resourcesbound activities.
Categories: eb3
0 Comments